Portfolio Companies

Portfolio Companies


Current Sector News Items

 
 
Tuesday, 27 September 2011
Acura Pharmaceuticals Awarded Key U.S. Patent
 
Thursday, 28 July 2011
David F. Azad Appointed to Board of Directors
 
Friday, 08 July 2011
FDA Approves Tamper-Resistant Pain Drug, Oxecta
 
Tuesday, 08 March 2011
Cambrooke Foods, Inc. Announces Series A Financing, Led by Galen Partners
 
Tuesday, 02 November 2010
Diclofenac Potassium Powder Well Tolerated, Provides Rapid Pain Relief for Migraine: Presented at CONy
 
Wednesday, 06 October 2010
Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ for the Acute Treatment of Migraine to the Women’s Health Market
 
 

Galen focuses on companies with proprietary products and services. We focus on companies within three key areas of healthcare: – medical devices & technology, specialty pharmaceuticals, and information technology & services.


Specialty Pharmaceuticals


Acura Pharmaceuticals, Inc. Acura Pharmaceuticals, Inc. (NASDAQ: ACUR)
Palatine, IL – Engaged in R&D and manufacture of innovative and proprietary abuse-deterrent and -resistant and tamper-resistant formulations for orally administered opioid-containing prescription analgesic products.
 
Cambrooke Foods, Inc. Cambrooke Foods, Inc. (Private)
Ayer, MA - Leading provider of high quality Specialty Medical Foods to those born with inborn errors of metabolism.
 
Nautilus Neurosciences, Inc. Nautilus Neurosciences, Inc. (Private)
Bedminster, NJ – A neurology-focused specialty pharmaceutical company that identifies and develops drugs that could benefit those affected by neurological disorders.